Soleno Therapeutics Inc (SLNO)

CIK 1484565 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Soleno Therapeutics Inc.

Recent SEC filings

FiledFormAccession number
Aug 13, 2026SCHEDULE 13G/A0000902219-26-000247
May 28, 202615-12G0001193125-26-245197
May 27, 2026EFFECT9999999995-26-001764
May 21, 2026POS AM0001193125-26-234441
May 21, 2026AW0001193125-26-234406
May 18, 2026S-8 POS0001193125-26-228122
May 18, 2026S-8 POS0001193125-26-228115
May 18, 202640001688712-26-000001
May 18, 2026S-8 POS0001193125-26-228121
May 18, 2026S-8 POS0001193125-26-228125
May 18, 2026S-8 POS0001193125-26-228047
May 18, 2026S-8 POS0001193125-26-228053
May 18, 2026S-8 POS0001193125-26-228051
May 18, 2026POSASR0001193125-26-228025
May 18, 2026S-8 POS0001193125-26-228119
May 18, 2026S-8 POS0001193125-26-228045
May 18, 2026SC 14D9/A0001193125-26-228011
May 18, 2026S-8 POS0001193125-26-228050
May 18, 2026S-8 POS0001193125-26-228055
May 18, 2026POSASR0001193125-26-228030
May 18, 2026S-8 POS0001193125-26-228117
May 18, 20268-K0001193125-26-228016
May 18, 2026S-8 POS0001193125-26-228118
May 18, 2026SC TO-T/A0001193125-26-227997
May 18, 202625-NSE0001354457-26-000469